High obesity prevalence, expanding cardiovascular indications, recent oral formulation approvals, and intensifying competition between semaglutide and tirzepatide are supporting U.S
Animal models of gastric and intestinal injury show accelerated recovery when exposed to BPC-157, with evidence pointing to protective effects on mucosal integrity PMID: 21030672
This schematic diagram explains several underlying principles and potential roles of garlic bioactives for hypertension management involving elicitation of NO bioavailability, enhancement of H2S production and CSE activity, inhibition of ACE and reduction of proliferation and migration of vascular smooth muscle cells
Eli Lilly, the company developing both retatrutide and tirzepatide, is running seven TRIUMPH trials covering obesity, type 2 diabetes, and specific metabolic conditions
However, understanding how and when to take it is equally important